Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2005-09

AUTHORS

Kasper Rossing, Katrine J Schjoedt, Berit R Jensen, Frans Boomsma, Hans-Henrik Parving

ABSTRACT

BACKGROUND: The purpose of this study was to evaluate the renoprotective effect as reflected by short-term changes in albuminuria of ultrahigh doses of irbesartan in type 2 diabetic patients with microalbuminuria. METHODS: This double-masked randomized crossover trial included 52 (41 males) hypertensive type 2 diabetic patients with microalbuminuria on ongoing antihypertensive medication. At inclusion, previous antihypertensive treatment was discontinued and replaced with bendroflumethiazide, 5 mg once daily, for the entire study. Following 2 months wash-out (baseline), patients were treated randomly with irbesartan 300, 600, and 900 mg once daily, each dose for 2 months. End points evaluated at the end of each study period included urinary albumin excretion rate (UAE) (mean of three 24-hour collections), 24-hour ambulatory blood pressure, and glomerular filtration rate (GFR) [chromium 51 ethylenediaminetetraacetic acid (51Cr-EDTA)]. RESULTS: Baseline values were: 24-hour UAE [geometric mean (95% CI)] 134 (103 to 170) mg/24 hours, ambulatory blood pressure [mean (SD)] 140 (10)/77 (7) mm Hg, and GFR 103 (19) mL/min/1.73 m2. All doses of irbesartan significantly reduced UAE, ambulatory blood pressure, and GFR from baseline. Reductions in UAE from baseline were 52% (46% to 57%), 49% (43% to 54%), and 59% (54% to 63%) with increasing doses of irbesartan (P < 0.01). UAE was reduced significantly more by irbesartan 900 mg compared with lower doses with an additional reduction in UAE of 15% (2% to 26%) by irbesartan 900 mg compared with 300 mg (P = 0.02). The greater reduction in albuminuria by irbesartan 900 vs. 300 mg was more pronounced in patients with UAE during irbesartan 300 mg above vs. below the median [31% (18% to 42%) vs. -9% (-25% to 6%), respectively (P < 0.05)]. With increasing doses systolic ambulatory blood pressure was reduced from baseline by 8 (4 to 12), 9 (5 to 13), and 9 (5 to13) mm Hg, and diastolic ambulatory blood pressure by 6 (4 to 7), 7 (6 to 9), and 7 (6 to 9) mm Hg (NS between doses). CONCLUSION: Ultrahigh dosing of irbesartan (900 mg once daily) is generally safe and offers additional renoprotection independent of changes in systemic blood pressure and GFR in comparison to the currently recommended dose of 300 mg. More... »

PAGES

1190-1198

Identifiers

URI

http://scigraph.springernature.com/pub.10.1111/j.1523-1755.2005.00511.x

DOI

http://dx.doi.org/10.1111/j.1523-1755.2005.00511.x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053471411

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16105050


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Albuminuria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aldosterone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiotensin II Type 1 Receptor Blockers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biphenyl Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Nephropathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerular Filtration Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Gentofte, Denmark. krossing@dadlnet.dk"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rossing", 
        "givenName": "Kasper", 
        "id": "sg:person.01024662571.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024662571.90"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Schjoedt", 
        "givenName": "Katrine J", 
        "id": "sg:person.0623062715.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623062715.35"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Jensen", 
        "givenName": "Berit R", 
        "id": "sg:person.01207444136.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207444136.05"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Boomsma", 
        "givenName": "Frans", 
        "id": "sg:person.01331665241.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331665241.81"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Parving", 
        "givenName": "Hans-Henrik", 
        "id": "sg:person.01036362324.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036362324.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2337/diacare.25.2007.s85", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002722133"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/14703203010020013401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003680333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/14703203010020013401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003680333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200109203451215", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004072321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.5.2.244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005128521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/17.8.1413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005514780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250100546", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006550186", 
          "https://doi.org/10.1007/s001250100546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250100546", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006550186", 
          "https://doi.org/10.1007/s001250100546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0272-6386(01)80115-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006885851"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/18.2.293", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007546101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa011303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007722379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa011161", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007846236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1046/j.1523-1755.2002.00536.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011320789", 
          "https://doi.org/10.1046/j.1523-1755.2002.00536.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2362.1999.00530.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011461161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ki.1990.217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015243785", 
          "https://doi.org/10.1038/ki.1990.217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.288.23.2981", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016077891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.12.3296", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017139995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa021778", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018344641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000024416.33113.0a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018363188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.0000154082.72286.2a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019798092"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.0000154082.72286.2a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019798092"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000078950", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023071028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.31.6.1311", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023922234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00041552-200401000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024434143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00041552-200401000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024434143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.1.150", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026438382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000139860.33974.28", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029162260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198402093100605", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029263631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1523-1755.2000.00386.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031002212", 
          "https://doi.org/10.1111/j.1523-1755.2000.00386.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/13.7.1682", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031625256"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa011489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032755890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250051259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035073261", 
          "https://doi.org/10.1007/s001250051259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250051259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035073261", 
          "https://doi.org/10.1007/s001250051259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2004.01194.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035881764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.8.2268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036378366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(98)00313-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038542351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079904x3861", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040600148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1523-1755.2004.00653.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044734909", 
          "https://doi.org/10.1111/j.1523-1755.2004.00653.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.0000154083.60540.10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045283544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.0000154083.60540.10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045283544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046314591", 
          "https://doi.org/10.1007/s001250050140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046314591", 
          "https://doi.org/10.1007/s001250050140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.27.5.1047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051349743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/16.4.771", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052239737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.asn.0000054495.96193.bf", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060319063"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.asn.0000054495.96193.bf", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060319063"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.asn.0000054495.96193.bf", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060319063"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.25.5.1042", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063338973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/00365517609068016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070978966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082678532", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-09", 
    "datePublishedReg": "2005-09-01", 
    "description": "BACKGROUND: The purpose of this study was to evaluate the renoprotective effect as reflected by short-term changes in albuminuria of ultrahigh doses of irbesartan in type 2 diabetic patients with microalbuminuria.\nMETHODS: This double-masked randomized crossover trial included 52 (41 males) hypertensive type 2 diabetic patients with microalbuminuria on ongoing antihypertensive medication. At inclusion, previous antihypertensive treatment was discontinued and replaced with bendroflumethiazide, 5 mg once daily, for the entire study. Following 2 months wash-out (baseline), patients were treated randomly with irbesartan 300, 600, and 900 mg once daily, each dose for 2 months. End points evaluated at the end of each study period included urinary albumin excretion rate (UAE) (mean of three 24-hour collections), 24-hour ambulatory blood pressure, and glomerular filtration rate (GFR) [chromium 51 ethylenediaminetetraacetic acid (51Cr-EDTA)].\nRESULTS: Baseline values were: 24-hour UAE [geometric mean (95% CI)] 134 (103 to 170) mg/24 hours, ambulatory blood pressure [mean (SD)] 140 (10)/77 (7) mm Hg, and GFR 103 (19) mL/min/1.73 m2. All doses of irbesartan significantly reduced UAE, ambulatory blood pressure, and GFR from baseline. Reductions in UAE from baseline were 52% (46% to 57%), 49% (43% to 54%), and 59% (54% to 63%) with increasing doses of irbesartan (P < 0.01). UAE was reduced significantly more by irbesartan 900 mg compared with lower doses with an additional reduction in UAE of 15% (2% to 26%) by irbesartan 900 mg compared with 300 mg (P = 0.02). The greater reduction in albuminuria by irbesartan 900 vs. 300 mg was more pronounced in patients with UAE during irbesartan 300 mg above vs. below the median [31% (18% to 42%) vs. -9% (-25% to 6%), respectively (P < 0.05)]. With increasing doses systolic ambulatory blood pressure was reduced from baseline by 8 (4 to 12), 9 (5 to 13), and 9 (5 to13) mm Hg, and diastolic ambulatory blood pressure by 6 (4 to 7), 7 (6 to 9), and 7 (6 to 9) mm Hg (NS between doses).\nCONCLUSION: Ultrahigh dosing of irbesartan (900 mg once daily) is generally safe and offers additional renoprotection independent of changes in systemic blood pressure and GFR in comparison to the currently recommended dose of 300 mg.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1111/j.1523-1755.2005.00511.x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1015319", 
        "issn": [
          "0085-2538", 
          "1523-1755"
        ], 
        "name": "Kidney International", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "68"
      }
    ], 
    "name": "Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria", 
    "pagination": "1190-1198", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "feb0b4c9c9855f15fed9595f6f2729b255a6970cb00eeb7ac821c2c6325eca4c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16105050"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0323470"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1111/j.1523-1755.2005.00511.x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053471411"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1111/j.1523-1755.2005.00511.x", 
      "https://app.dimensions.ai/details/publication/pub.1053471411"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000426.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/ki/journal/v68/n3/full/4496198a.html"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1111/j.1523-1755.2005.00511.x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1111/j.1523-1755.2005.00511.x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1111/j.1523-1755.2005.00511.x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1111/j.1523-1755.2005.00511.x'


 

This table displays all metadata directly associated to this object as RDF triples.

302 TRIPLES      21 PREDICATES      90 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1111/j.1523-1755.2005.00511.x schema:about N1f056f011bee4c3da050c621334837f0
2 N34f5c5343f264565bb17a2e9bb84319d
3 N3772b835e85b489683ff8a7d99277680
4 N3a5c6c3b740343acabd304377c7dff3d
5 N40a76326193e4f1fb52801b94e767e6c
6 N5c19b51c8dbf4829939bc38724dbfd1f
7 N6a4278d704594947b119a1409439d152
8 N791545b3ba8e47e5820744bae5bd0645
9 N7c144987424c4a35a815c9dd6d4a4dfa
10 N92f1a6e9ddc84c139d723618e8e2d6a8
11 N9868a112ed304b1aba6bcfe15977b990
12 N9e7265126bc842d2b0674ed78c1ef0ef
13 Nacaf3059dc434026bf4dd3d39d61bd9c
14 Nb62f505fb6444203aa1e55cfacbd7023
15 Nc2d20e311ae24b5fb3b980bff0542c4a
16 Nc8de9151681d4f4f9a57026a8c4d22dd
17 Nd00799e4a7ca440392d4b46dec38d7a4
18 Nda3672937f7640c0be14f4e606dc77ba
19 Nf7aed25a33614154864f02f5ff6676e1
20 Nfef9fcedd51b4805a7f1c7da750b5a48
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N722f7c58b818427d9fabf7ff2b6a3834
24 schema:citation sg:pub.10.1007/s001250050140
25 sg:pub.10.1007/s001250051259
26 sg:pub.10.1007/s001250100546
27 sg:pub.10.1038/ki.1990.217
28 sg:pub.10.1046/j.1523-1755.2002.00536.x
29 sg:pub.10.1111/j.1523-1755.2000.00386.x
30 sg:pub.10.1111/j.1523-1755.2004.00653.x
31 https://app.dimensions.ai/details/publication/pub.1082678532
32 https://doi.org/10.1001/jama.288.23.2981
33 https://doi.org/10.1016/s0002-9149(98)00313-0
34 https://doi.org/10.1016/s0272-6386(01)80115-3
35 https://doi.org/10.1046/j.1365-2362.1999.00530.x
36 https://doi.org/10.1056/nejm198402093100605
37 https://doi.org/10.1056/nejm200109203451215
38 https://doi.org/10.1056/nejmoa011161
39 https://doi.org/10.1056/nejmoa011303
40 https://doi.org/10.1056/nejmoa011489
41 https://doi.org/10.1056/nejmoa021778
42 https://doi.org/10.1093/ndt/13.7.1682
43 https://doi.org/10.1093/ndt/16.4.771
44 https://doi.org/10.1093/ndt/17.8.1413
45 https://doi.org/10.1093/ndt/18.2.293
46 https://doi.org/10.1097/00041552-200401000-00012
47 https://doi.org/10.1097/01.asn.0000054495.96193.bf
48 https://doi.org/10.1111/j.1464-5491.2004.01194.x
49 https://doi.org/10.1159/000078950
50 https://doi.org/10.1161/01.cir.0000024416.33113.0a
51 https://doi.org/10.1161/01.cir.0000139860.33974.28
52 https://doi.org/10.1161/01.hyp.0000154082.72286.2a
53 https://doi.org/10.1161/01.hyp.0000154083.60540.10
54 https://doi.org/10.1161/01.hyp.25.5.1042
55 https://doi.org/10.1161/01.hyp.31.6.1311
56 https://doi.org/10.1161/01.hyp.5.2.244
57 https://doi.org/10.1177/14703203010020013401
58 https://doi.org/10.1185/030079904x3861
59 https://doi.org/10.2337/diacare.25.2007.s85
60 https://doi.org/10.2337/diacare.26.1.150
61 https://doi.org/10.2337/diacare.26.12.3296
62 https://doi.org/10.2337/diacare.26.8.2268
63 https://doi.org/10.2337/diacare.27.5.1047
64 https://doi.org/10.3109/00365517609068016
65 schema:datePublished 2005-09
66 schema:datePublishedReg 2005-09-01
67 schema:description BACKGROUND: The purpose of this study was to evaluate the renoprotective effect as reflected by short-term changes in albuminuria of ultrahigh doses of irbesartan in type 2 diabetic patients with microalbuminuria. METHODS: This double-masked randomized crossover trial included 52 (41 males) hypertensive type 2 diabetic patients with microalbuminuria on ongoing antihypertensive medication. At inclusion, previous antihypertensive treatment was discontinued and replaced with bendroflumethiazide, 5 mg once daily, for the entire study. Following 2 months wash-out (baseline), patients were treated randomly with irbesartan 300, 600, and 900 mg once daily, each dose for 2 months. End points evaluated at the end of each study period included urinary albumin excretion rate (UAE) (mean of three 24-hour collections), 24-hour ambulatory blood pressure, and glomerular filtration rate (GFR) [chromium 51 ethylenediaminetetraacetic acid (51Cr-EDTA)]. RESULTS: Baseline values were: 24-hour UAE [geometric mean (95% CI)] 134 (103 to 170) mg/24 hours, ambulatory blood pressure [mean (SD)] 140 (10)/77 (7) mm Hg, and GFR 103 (19) mL/min/1.73 m2. All doses of irbesartan significantly reduced UAE, ambulatory blood pressure, and GFR from baseline. Reductions in UAE from baseline were 52% (46% to 57%), 49% (43% to 54%), and 59% (54% to 63%) with increasing doses of irbesartan (P < 0.01). UAE was reduced significantly more by irbesartan 900 mg compared with lower doses with an additional reduction in UAE of 15% (2% to 26%) by irbesartan 900 mg compared with 300 mg (P = 0.02). The greater reduction in albuminuria by irbesartan 900 vs. 300 mg was more pronounced in patients with UAE during irbesartan 300 mg above vs. below the median [31% (18% to 42%) vs. -9% (-25% to 6%), respectively (P < 0.05)]. With increasing doses systolic ambulatory blood pressure was reduced from baseline by 8 (4 to 12), 9 (5 to 13), and 9 (5 to13) mm Hg, and diastolic ambulatory blood pressure by 6 (4 to 7), 7 (6 to 9), and 7 (6 to 9) mm Hg (NS between doses). CONCLUSION: Ultrahigh dosing of irbesartan (900 mg once daily) is generally safe and offers additional renoprotection independent of changes in systemic blood pressure and GFR in comparison to the currently recommended dose of 300 mg.
68 schema:genre research_article
69 schema:inLanguage en
70 schema:isAccessibleForFree true
71 schema:isPartOf N95d27180f8be40e486ec7de93f401fe8
72 Ncd503d465b0b4a968cc2ea4d671c1336
73 sg:journal.1015319
74 schema:name Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
75 schema:pagination 1190-1198
76 schema:productId N41ca63be752f4f00bb92cb62fd297c46
77 N5f2cc1789a134a6db856d85514188b28
78 Nd7634c962c104b79aea302bf677fb043
79 Nee128608812e4784bee7925f1899b630
80 Nee6fe938b8214032a1f8f423c1a17e6b
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053471411
82 https://doi.org/10.1111/j.1523-1755.2005.00511.x
83 schema:sdDatePublished 2019-04-10T15:39
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N25465d58138e48ef9a06b91eea276f3d
86 schema:url http://www.nature.com/ki/journal/v68/n3/full/4496198a.html
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N1f056f011bee4c3da050c621334837f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Male
92 rdf:type schema:DefinedTerm
93 N25465d58138e48ef9a06b91eea276f3d schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N34f5c5343f264565bb17a2e9bb84319d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Glycated Hemoglobin A
97 rdf:type schema:DefinedTerm
98 N3772b835e85b489683ff8a7d99277680 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Humans
100 rdf:type schema:DefinedTerm
101 N37f9f10df230462a9beb6f6fee400e26 rdf:first sg:person.01331665241.81
102 rdf:rest N7e182933999e46a4814fe962609db257
103 N3a5c6c3b740343acabd304377c7dff3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Diabetic Nephropathies
105 rdf:type schema:DefinedTerm
106 N40a76326193e4f1fb52801b94e767e6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Angiotensin II Type 1 Receptor Blockers
108 rdf:type schema:DefinedTerm
109 N41ca63be752f4f00bb92cb62fd297c46 schema:name doi
110 schema:value 10.1111/j.1523-1755.2005.00511.x
111 rdf:type schema:PropertyValue
112 N521b917aa2074dd08e266f9cc2fb86f4 rdf:first sg:person.01207444136.05
113 rdf:rest N37f9f10df230462a9beb6f6fee400e26
114 N5c19b51c8dbf4829939bc38724dbfd1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Tetrazoles
116 rdf:type schema:DefinedTerm
117 N5f2cc1789a134a6db856d85514188b28 schema:name readcube_id
118 schema:value feb0b4c9c9855f15fed9595f6f2729b255a6970cb00eeb7ac821c2c6325eca4c
119 rdf:type schema:PropertyValue
120 N6a4278d704594947b119a1409439d152 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Blood Pressure
122 rdf:type schema:DefinedTerm
123 N6c923451c395415cbd5771d029da008d rdf:first sg:person.0623062715.35
124 rdf:rest N521b917aa2074dd08e266f9cc2fb86f4
125 N722f7c58b818427d9fabf7ff2b6a3834 rdf:first sg:person.01024662571.90
126 rdf:rest N6c923451c395415cbd5771d029da008d
127 N791545b3ba8e47e5820744bae5bd0645 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Aged
129 rdf:type schema:DefinedTerm
130 N7c144987424c4a35a815c9dd6d4a4dfa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Sodium
132 rdf:type schema:DefinedTerm
133 N7e182933999e46a4814fe962609db257 rdf:first sg:person.01036362324.03
134 rdf:rest rdf:nil
135 N92f1a6e9ddc84c139d723618e8e2d6a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Renin
137 rdf:type schema:DefinedTerm
138 N95d27180f8be40e486ec7de93f401fe8 schema:issueNumber 3
139 rdf:type schema:PublicationIssue
140 N9868a112ed304b1aba6bcfe15977b990 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Aldosterone
142 rdf:type schema:DefinedTerm
143 N9e7265126bc842d2b0674ed78c1ef0ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Treatment Outcome
145 rdf:type schema:DefinedTerm
146 Nacaf3059dc434026bf4dd3d39d61bd9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Diabetes Mellitus, Type 2
148 rdf:type schema:DefinedTerm
149 Nb62f505fb6444203aa1e55cfacbd7023 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Lipids
151 rdf:type schema:DefinedTerm
152 Nc2d20e311ae24b5fb3b980bff0542c4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Cross-Over Studies
154 rdf:type schema:DefinedTerm
155 Nc8de9151681d4f4f9a57026a8c4d22dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Biphenyl Compounds
157 rdf:type schema:DefinedTerm
158 Ncd503d465b0b4a968cc2ea4d671c1336 schema:volumeNumber 68
159 rdf:type schema:PublicationVolume
160 Nd00799e4a7ca440392d4b46dec38d7a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Albuminuria
162 rdf:type schema:DefinedTerm
163 Nd7634c962c104b79aea302bf677fb043 schema:name pubmed_id
164 schema:value 16105050
165 rdf:type schema:PropertyValue
166 Nda3672937f7640c0be14f4e606dc77ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Middle Aged
168 rdf:type schema:DefinedTerm
169 Nee128608812e4784bee7925f1899b630 schema:name nlm_unique_id
170 schema:value 0323470
171 rdf:type schema:PropertyValue
172 Nee6fe938b8214032a1f8f423c1a17e6b schema:name dimensions_id
173 schema:value pub.1053471411
174 rdf:type schema:PropertyValue
175 Nf7aed25a33614154864f02f5ff6676e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Female
177 rdf:type schema:DefinedTerm
178 Nfef9fcedd51b4805a7f1c7da750b5a48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Glomerular Filtration Rate
180 rdf:type schema:DefinedTerm
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
185 schema:name Clinical Sciences
186 rdf:type schema:DefinedTerm
187 sg:journal.1015319 schema:issn 0085-2538
188 1523-1755
189 schema:name Kidney International
190 rdf:type schema:Periodical
191 sg:person.01024662571.90 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
192 schema:familyName Rossing
193 schema:givenName Kasper
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024662571.90
195 rdf:type schema:Person
196 sg:person.01036362324.03 schema:familyName Parving
197 schema:givenName Hans-Henrik
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036362324.03
199 rdf:type schema:Person
200 sg:person.01207444136.05 schema:familyName Jensen
201 schema:givenName Berit R
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207444136.05
203 rdf:type schema:Person
204 sg:person.01331665241.81 schema:familyName Boomsma
205 schema:givenName Frans
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331665241.81
207 rdf:type schema:Person
208 sg:person.0623062715.35 schema:familyName Schjoedt
209 schema:givenName Katrine J
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623062715.35
211 rdf:type schema:Person
212 sg:pub.10.1007/s001250050140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046314591
213 https://doi.org/10.1007/s001250050140
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s001250051259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035073261
216 https://doi.org/10.1007/s001250051259
217 rdf:type schema:CreativeWork
218 sg:pub.10.1007/s001250100546 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006550186
219 https://doi.org/10.1007/s001250100546
220 rdf:type schema:CreativeWork
221 sg:pub.10.1038/ki.1990.217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015243785
222 https://doi.org/10.1038/ki.1990.217
223 rdf:type schema:CreativeWork
224 sg:pub.10.1046/j.1523-1755.2002.00536.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011320789
225 https://doi.org/10.1046/j.1523-1755.2002.00536.x
226 rdf:type schema:CreativeWork
227 sg:pub.10.1111/j.1523-1755.2000.00386.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031002212
228 https://doi.org/10.1111/j.1523-1755.2000.00386.x
229 rdf:type schema:CreativeWork
230 sg:pub.10.1111/j.1523-1755.2004.00653.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044734909
231 https://doi.org/10.1111/j.1523-1755.2004.00653.x
232 rdf:type schema:CreativeWork
233 https://app.dimensions.ai/details/publication/pub.1082678532 schema:CreativeWork
234 https://doi.org/10.1001/jama.288.23.2981 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016077891
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s0002-9149(98)00313-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038542351
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s0272-6386(01)80115-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006885851
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1046/j.1365-2362.1999.00530.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011461161
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1056/nejm198402093100605 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029263631
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1056/nejm200109203451215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004072321
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1056/nejmoa011161 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007846236
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1056/nejmoa011303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007722379
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1056/nejmoa011489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032755890
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1056/nejmoa021778 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018344641
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1093/ndt/13.7.1682 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031625256
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1093/ndt/16.4.771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052239737
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1093/ndt/17.8.1413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005514780
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1093/ndt/18.2.293 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007546101
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1097/00041552-200401000-00012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024434143
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1097/01.asn.0000054495.96193.bf schema:sameAs https://app.dimensions.ai/details/publication/pub.1060319063
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1111/j.1464-5491.2004.01194.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1035881764
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1159/000078950 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023071028
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1161/01.cir.0000024416.33113.0a schema:sameAs https://app.dimensions.ai/details/publication/pub.1018363188
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1161/01.cir.0000139860.33974.28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029162260
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1161/01.hyp.0000154082.72286.2a schema:sameAs https://app.dimensions.ai/details/publication/pub.1019798092
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1161/01.hyp.0000154083.60540.10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045283544
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1161/01.hyp.25.5.1042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063338973
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1161/01.hyp.31.6.1311 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023922234
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1161/01.hyp.5.2.244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005128521
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1177/14703203010020013401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003680333
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1185/030079904x3861 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040600148
287 rdf:type schema:CreativeWork
288 https://doi.org/10.2337/diacare.25.2007.s85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002722133
289 rdf:type schema:CreativeWork
290 https://doi.org/10.2337/diacare.26.1.150 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026438382
291 rdf:type schema:CreativeWork
292 https://doi.org/10.2337/diacare.26.12.3296 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017139995
293 rdf:type schema:CreativeWork
294 https://doi.org/10.2337/diacare.26.8.2268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036378366
295 rdf:type schema:CreativeWork
296 https://doi.org/10.2337/diacare.27.5.1047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051349743
297 rdf:type schema:CreativeWork
298 https://doi.org/10.3109/00365517609068016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070978966
299 rdf:type schema:CreativeWork
300 https://www.grid.ac/institutes/grid.419658.7 schema:alternateName Steno Diabetes Center
301 schema:name Steno Diabetes Center, Gentofte, Denmark. krossing@dadlnet.dk
302 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...